MENU
+Compare
UCBJY
Stock ticker: OTC
AS OF
Apr 4 closing price
Price
$81.73
Change
-$6.58 (-7.45%)
Capitalization
31.62B

UCBJY UCB S.A. Forecast, Technical & Fundamental Analysis

UCB is a Belgium-based biopharma firm focused on the development of novel therapies for the treatment of central nervous system and immunologic diseases... Show more

UCBJY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for UCBJY with price predictions
Apr 04, 2025

UCBJY in +0.59% Uptrend, advancing for three consecutive days on April 03, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where UCBJY advanced for three days, in of 304 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for UCBJY's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 26, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on UCBJY as a result. In of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for UCBJY turned negative on March 20, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 59 similar instances when the indicator turned negative. In of the 59 cases the stock turned lower in the days that followed. This puts the odds of success at .

UCBJY moved below its 50-day moving average on March 20, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for UCBJY crossed bearishly below the 50-day moving average on March 26, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where UCBJY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

UCBJY broke above its upper Bollinger Band on March 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for UCBJY entered a downward trend on April 04, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.840) is normal, around the industry mean (13.044). P/E Ratio (27.353) is within average values for comparable stocks, (63.096). Projected Growth (PEG Ratio) (2.523) is also within normal values, averaging (1.822). Dividend Yield (0.009) settles around the average of (0.025) among similar stocks. P/S Ratio (4.739) is also within normal values, averaging (249.684).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. UCBJY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
UCBJY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

UCBJY is expected to report earnings to fall 85.79% to 11 cents per share on February 28

UCB S.A. UCBJY Stock Earnings Reports
Q4'23
Est.
$0.12
Q2'23
Missed
by $0.08
The last earnings report on July 27 showed earnings per share of 83 cents, missing the estimate of 91 cents. With 39.65K shares outstanding, the current market capitalization sits at 31.62B.
A.I.Advisor
published Dividends

UCBJY paid dividends on May 15, 2024

UCB S.A. UCBJY Stock Dividends
А dividend of $0.72 per share was paid with a record date of May 15, 2024, and an ex-dividend date of April 26, 2024. Read more...
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Allee de la Recherche, 60
Phone
+32 25599999
Employees
8703
Web
https://www.ucb.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSVPX14.03-0.68
-4.62%
Goldman Sachs Small/Mid Cap Value P
NSEIX19.96-1.09
-5.18%
Nicholas Equity Income I
RALYX9.89-0.55
-5.27%
Lazard Real Assets R6
HQIFX18.68-1.11
-5.61%
Hartford Equity Income F
MLPGX6.70-0.57
-7.84%
Invesco SteelPath MLP Alpha C

UCBJY and Stocks

Correlation & Price change

A.I.dvisor tells us that UCBJY and GBIO have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that UCBJY and GBIO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UCBJY
1D Price
Change %
UCBJY100%
-7.45%
GBIO - UCBJY
28%
Poorly correlated
-6.29%
VANI - UCBJY
26%
Poorly correlated
-3.03%
ABOS - UCBJY
24%
Poorly correlated
-1.02%
TNYA - UCBJY
23%
Poorly correlated
-4.08%
ARWR - UCBJY
23%
Poorly correlated
-11.44%
More